Enanta

$49.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.26 (-2.49%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Enanta and other stocks, options, and ETFs commission-free!

About ENTA

Enanta Pharmaceuticals, Inc. operates as a biotechnology company. It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. The firm offers the medicine under the brands Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA. The listed name for ENTA is Enanta Pharmaceuticals, Inc. Common Stock.

CEO

Jay R. Luly

Employees

141

Headquarters

Watertown, Massachusetts

Founded

1995

Market Cap

989.49M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

152.87K

High Today

$51.06

Low Today

$47.96

Open Price

$50.03

Volume

270.99K

52 Week High

$58.59

52 Week Low

$38.40

Analyst Ratings

56%

of 9 ratings

Buy

56%

Hold

33%

Sell

11%

ENTA Earnings

-$1.46

-$0.76

-$0.05

$0.65

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected May 6, After Hours